Initial Statement of Beneficial Ownership (3)
10 March 2020 - 9:27AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Advanced Biomedical Technologies Inc. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/9/2020
|
3. Issuer Name and Ticker or Trading Symbol
Advanced Biomedical Technologies Inc. [ABMT]
|
|
(Last)
(First)
(Middle)
PUYI SHENG, 350 FIFTH AVE., 59TH FLOOR |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) ___X___ Other (specify below)
/ Chief Medical Officer |
|
(Street)
NEW YORK, NY 10118
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 100000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Advanced Biomedical Technologies Inc.
PUYI SHENG
350 FIFTH AVE., 59TH FLOOR
NEW YORK, NY 10118 |
|
|
| Chief Medical Officer |
Signatures
|
| Kai Gui | | 3/9/2020 |
| **Signature of Reporting Person | Date |
Advanced BioMedical Tech... (CE) (USOTC:ABMT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Advanced BioMedical Tech... (CE) (USOTC:ABMT)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Advanced BioMedical Technologies Inc (CE) (OTCMarkets): 0 recent articles
More Advanced Biomedical Technologies Inc. News Articles
